You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

FRAGMIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Fragmin patents expire, and what generic alternatives are available?

Fragmin is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in FRAGMIN is dalteparin sodium. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dalteparin sodium profile page.

Summary for FRAGMIN
Drug patent expirations by year for FRAGMIN
Drug Prices for FRAGMIN

See drug prices for FRAGMIN

Recent Clinical Trials for FRAGMIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
ItreasPhase 3
IQVIA BiotechPhase 3
Anthos Therapeutics, Inc.Phase 3

See all FRAGMIN clinical trials

Pharmacology for FRAGMIN
Anatomical Therapeutic Chemical (ATC) Classes for FRAGMIN

US Patents and Regulatory Information for FRAGMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer FRAGMIN dalteparin sodium INJECTABLE;INJECTION 020287-008 Apr 4, 2002 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-012 Mar 15, 2022 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-005 Apr 4, 2002 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-007 Apr 4, 2002 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-009 May 1, 2007 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-001 Dec 22, 1994 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-003 Mar 18, 1996 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FRAGMIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-001 Dec 22, 1994 ⤷  Try a Trial ⤷  Try a Trial
Pfizer FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-003 Mar 18, 1996 ⤷  Try a Trial ⤷  Try a Trial
Pfizer FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-004 Jan 30, 1998 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for FRAGMIN

See the table below for patents covering FRAGMIN around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 8001383 ⤷  Try a Trial
Japan S56500066 ⤷  Try a Trial
Austria 8998 ⤷  Try a Trial
Norway 150801 ⤷  Try a Trial
Denmark 380280 ⤷  Try a Trial
Denmark 160764 ⤷  Try a Trial
Norway 802626 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.